Mary Heyer, PhD
img_Mary Heyer
INSTRUCTOR | Neuroscience
microRNAs in neurodevelopmental disorders and addiction
microRNAs and noncoding RNAs are potent regulators of gene expression and are enriched in the nervous system. Their diversity and abundance, dramatically increased in human brain, may contribute to advanced complexity of neuronal circuits and behavior. microRNA dysfunction is implicated in psychiatric disorders; however, the underlying mechanisms are poorly understood. I use genetic, viral, molecular, and behavioral approaches to target specific microRNAs in mice and explore their functions in vivo. My projects currently focus on (1) the regulation of Purkinje cell gene expression, activity, and downstream behaviors by schizophrenia- and autism- associated cerebellar microRNAs and (2) the regulation of cocaine-seeking behavior and anxiety-related behaviors by activity-dependent microRNAs.

MA, University of Cambridge

PhD, Duke University

N/A, The Scripps Research Institute, Florida

N/A, Icahn School of Medicine at Mount Sinai

2015

Seaver Foundation Postdoctal Fellowship

Seaver Foundation

2007

Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship

NINDS

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Heyer has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.